News Baudax Bio, Inc.

Equities

Market Closed - OTC Markets Other stock markets 08:00:53 01/05/2024 pm IST			5-day change	1st Jan Change
0.01 ^USD	0.00%		-5.66%	-54.55%

22/02	Baudax Bio, Inc. Filed for Bankruptcy	CI
2023	Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Baudax Bio, Inc. Filed for Bankruptcy	22/02	CI
Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11	CI
Baudax Bio, Inc.(OTCPK:BXRX) dropped from S&P TMI Index	20/11	CI
Baudax Bio, Inc.(OTCPK:BXRX) dropped from NASDAQ Composite Index	16/11	CI
Baudax Bio : Change in Certifying Accountants - Form 8-K	25/23/25	PU
Baudax Bio Announces Corporate Update	18/23/18	AQ
Baudax Bio, Inc. to Initiate TI-168 Clinical Development	18/23/18	CI
Sector Update: Health Care Stocks Advancing in Late Afternoon Trading	07/23/07	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	06/23/06	MT
Baudax Bio Appoints Natalie McAndrew as Interim Finance Chief	06/23/06	MT
Baudax Bio : Corporate Overview	06/23/06	PU
Baudax Bio, Inc. Announces Board Changes	06/23/06	CI
Baudax Bio, Inc. Announces Chief Financial Officer Changes	06/23/06	CI
Wall Street Set to Open Higher; Personal Consumption Inflation Data Lower Than Expected	29/23/29	MT
Top Premarket Decliners	29/23/29	MT
Baudax Bio, Inc. Announces Orphan Drug Designation Granted by U.S. Fda for Ti-168 for the Treatment of Hemophilia A with Inhibitors	29/23/29	CI
Sector Update: Health Care Stocks Rising in Late Afternoon Trading	29/23/29	MT
Sector Update: Health Care	29/23/29	MT
Top Midday Gainers	28/23/28	MT
Baudax Bio Shares Double After Orphan Drug Designation for TI-168	28/23/28	DJ

No results for this search